Savant Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.5M Buy
265,777
+41,994
+19% +$9.79M 0.2% 75
2026
Q1
$54.7M Buy
223,783
+18,538
+9% +$4.32M 0.26% 57
2025
Q4
$42.5M Sell
205,245
-2,472
-1% -$489K 0.24% 64
2025
Q3
$38.5M Buy
207,717
+4,573
+2% +$783K 0.23% 68
2025
Q2
$31M Buy
203,144
+4,762
+2% +$732K 0.22% 68
2025
Q1
$32.9M Sell
198,382
-49,874
-20% -$7.8M 0.28% 60
2024
Q4
$35.9M Buy
248,256
+729
+0.3% +$113K 0.28% 63
2024
Q3
$40.1M Buy
247,527
+16,120
+7% +$2.57M 0.33% 57
2024
Q2
$33.8M Buy
231,407
+7,582
+3% +$1.13M 0.34% 60
2024
Q1
$35.4M Buy
223,825
+6,572
+3% +$1.05M 0.41% 49
2023
Q4
$34.1M Sell
217,253
-8,500
-4% -$1.3M 0.44% 45
2023
Q3
$35.2M Sell
225,753
-25,353
-10% -$4.18M 0.52% 38
2023
Q2
$41.6M Buy
251,106
+57,950
+30% +$9.35M 0.65% 29
2023
Q1
$29.9M Buy
193,156
+19,996
+12% +$3.23M 0.56% 30
2022
Q4
$25.9M Buy
173,160
+131,284
+314% +$22.7M 0.63% 30
2022
Q3
$6.84M Sell
41,876
-415
-1% -$70.2K 0.21% 69
2022
Q2
$7.51M Buy
42,291
+4,526
+12% +$806K 0.23% 63
2022
Q1
$6.69M Buy
37,765
+684
+2% +$116K 0.22% 64
2021
Q4
$6.34M Buy
37,081
+639
+2% +$105K 0.21% 67
2021
Q3
$5.88M Buy
36,442
+559
+2% +$95.4K 0.21% 66
2021
Q2
$5.91M Sell
35,883
-544
-1% -$90.1K 0.24% 55
2021
Q1
$5.99M Buy
36,427
+1,014
+3% +$164K 0.32% 50
2020
Q4
$5.57M Sell
35,413
-1,655
-4% -$244K 0.32% 50
2020
Q3
$5.52M Buy
37,068
+38
+0.1% +$5.62K 0.38% 48
2020
Q2
$5.21M Buy
37,030
+2,580
+7% +$376K 0.39% 49
2020
Q1
$4.52M Buy
34,450
+2,084
+6% +$296K 0.43% 48
2019
Q4
$4.72M Buy
32,366
+1,195
+4% +$162K 0.58% 39
2019
Q3
$4.03M Sell
31,171
-466
-1% -$61.4K 0.56% 44
2019
Q2
$4.41M Buy
31,637
+393
+1% +$54.4K 0.62% 38
2019
Q1
$4.37M Sell
31,244
-19
-0.1% -$2.54K 0.82% 26
2018
Q4
$4.03M Buy
31,263
+801
+3% +$112K 0.84% 28
2018
Q3
$4.21M Buy
30,462
+300
+1% +$39.9K 0.76% 29
2018
Q2
$3.66M Buy
30,162
+72
+0.2% +$8.98K 0.78% 27
2018
Q1
$3.86M Sell
30,090
-887
-3% -$120K 0.81% 21
2017
Q4
$4.33M Buy
30,977
+1,009
+3% +$141K 0.91% 21
2017
Q3
$3.9M Sell
29,968
-55
-0.2% -$7.29K 0.87% 22
2017
Q2
$3.97M Buy
30,023
+197
+0.7% +$25.1K 0.94% 19
2017
Q1
$3.71M Buy
29,826
+618
+2% +$73.8K 0.92% 20
2016
Q4
$3.37M Sell
29,208
-65
-0.2% -$7.51K 0.9% 20
2016
Q3
$3.46M Buy
29,273
+857
+3% +$104K 0.95% 17
2016
Q2
$3.45M Buy
28,416
+3,855
+16% +$438K 0.99% 14
2016
Q1
$2.66M Buy
24,561
+87
+0.4% +$9.01K 0.81% 21
2015
Q4
$2.51M Buy
24,474
+3,963
+19% +$399K 0.78% 25
2015
Q3
$1.92M Sell
20,511
-530
-3% -$51.3K 0.69% 25
2015
Q2
$2.05M Sell
21,041
-112
-0.5% -$11.2K 0.69% 23
2015
Q1
$2.13M Buy
21,153
+1,701
+9% +$173K 0.75% 21
2014
Q4
$2.03M Buy
19,452
+1,193
+7% +$126K 0.77% 22
2014
Q3
$1.95M Buy
18,259
+1,814
+11% +$188K 0.83% 20
2014
Q2
$1.72M Buy
16,445
+196
+1% +$19.8K 0.74% 22
2014
Q1
$1.6M Buy
16,249
+260
+2% +$24.1K 0.74% 25
2013
Q4
$1.46M Sell
15,989
-452
-3% -$41.7K 0.72% 27
2013
Q3
$1.43M Buy
16,441
+460
+3% +$41.3K 0.78% 25
2013
Q2
$1.37M Buy
+15,981
New +$1.36M 0.8% 26

Other funds holding JNJ

Savant Capital's JNJ Position: Q2 2026 in Review

Savant Capital increased its Johnson & Johnson (JNJ) stake by 19% in Q2 2026, buying an estimated $9.79M and bringing the position to 265,777 shares worth $67.5M. The position accounts for 0.2% of the portfolio, ranked #75.

Savant Capital first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Savant Capital held 265,777 shares of Johnson & Johnson worth $67.5M as of Q2 2026.
  • Savant Capital bought 41,994 Johnson & Johnson shares in Q2 2026, an estimated $9.79M.
  • Johnson & Johnson made up 0.2% of Savant Capital's portfolio in Q2 2026, its #75 holding.
  • Savant Capital first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.